View Information Collection Request (ICR) Package
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0915-0327
ICR Reference No:
202208-0915-001
Status:
Active
Previous ICR Reference No:
201908-0915-001
Agency/Subagency:
HHS/HSA
Agency Tracking No:
20345
Title:
Enrollment and Re-Certification of Entities in the 340B Drug Pricing Program and Collection of Manufacturer Data to Verify 340B Drug Pricing Program Ceiling Price Calculations
Type of Information Collection:
Revision of a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved with change
Conclusion Date:
01/05/2023
Retrieve Notice of Action (NOA)
Date Received in OIRA:
11/29/2022
Terms of Clearance:
Inventory as of this Action
Requested
Previously Approved
Expiration Date
01/31/2026
36 Months From Approved
01/31/2023
Responses
109,982
0
94,629
Time Burden (Hours)
59,359
0
44,660
Cost Burden (Dollars)
0
0
0
Abstract:
Section 602 of Public Law 102–585, the Veterans Health Care Act of 1992, enacted section 340B of the Public Health Service (PHS) Act, which instructs HHS to enter into a Pharmaceutical Pricing Agreement (PPA) with manufacturers of covered outpatient drugs. Manufacturers are required by section 1927(a)(5)(A) of the Social Security Act to enter into agreements with the Secretary of HHS (Secretary) that comply with section 340B of the PHS Act if they participate in the Medicaid Drug Rebate Program. When a drug manufacturer signs a PPA, it is opting into the 340B Drug Pricing Program (340B Program), and it agrees to the statutory requirement that prices charged for covered outpatient drugs to covered entities will not exceed statutorily defined 340B ceiling prices. When an eligible covered entity voluntarily decides to enroll and participate in the 340B Program, it accepts responsibility for ensuring compliance with all provisions of the 340B Program, including all associated costs. Covered entities that choose to participate in the 340B Program must comply with the requirements of section 340B(a)(5) of the PHS Act. Section 340B(a)(5)(A) of the PHS Act prohibits a covered entity from accepting a discount for a drug that would also generate a Medicaid rebate. Further, section 340B(a)(5)(B) of the PHS Act prohibits a covered entity from reselling or otherwise transferring a discounted drug to a person who is not a patient of the covered entity.
Authorizing Statute(s):
PL:
Pub.L. 102 - 585 601-602
Name of Law: Veterans Health Care Act of 1992
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
87 FR 35983
07/14/2022
30-day Notice:
Federal Register Citation:
Citation Date:
87 FR 65212
10/28/2022
Did the Agency receive public comments on this ICR?
Yes
Number of Information Collection (IC) in this ICR:
7
IC Title
Form No.
Form Name
Contracted Pharmacy Services Registration and Recertifications
3.1, 3.2
Contract Pharmacy Registration.pdf
,
Contract Pharmacy Termination.pdf
Hospital Enrollment, Additions and Recertifcations
1.1, 1.2, 1.4, 1.10, 1.5, 1.3, 1.6, 1.11, 1.8, 1.7, 1.9
340B Registration DSH Parent.pdf
,
340B Registration Children's Hospital.pdf
,
340B Registration CAN Parent.pdf
,
340B Registration Hospital Outpatient Facility.pdf
,
340B Registration RRC and SCH Parent.pdf
,
340B Registration CAH Parent.pdf
,
340B Recertification DSH.pdf
,
340B Recertification SCH and RRC.pdf
,
340B Recertification Childrens Hospital.pdf
,
340B Recertification CAH.pdf
,
340B Recertification CAN.pdf
Manufacturer Data Required to Verify 340 B Ceiling Price
7
Manufacturer Data Fields for 340B Ceiling Price.pdf
Pharmaceutical Pricing Agreement and PPA Addendum
6
Manufacturer PPA.pdf
Registrations and Recertifications for Entities other than Hospitals
2.1, 2.2, 2.3, 2.4, 2.5, 2.6
340B Registration CHC and FQHCLA.pdf
,
340B Registration STD and TB.pdf
,
340B Registration-Covered Entities All Other Non-Hospitals.pdf
,
340B Recertfication STD and TB.pdf
,
340B Recertification CHC and FQHCLA.pdf
,
340B Recertification Covered Entities All Other Non-Hospital..pdf
Submission of Administrative Changes for Any Manufacturer
5
340B Manufacturer Change Form.pdf
Submission of Administrative Changes for any Covered Entities
4
340B Covered Entity Change Request.pdf
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
109,982
94,629
0
15,353
0
0
Annual Time Burden (Hours)
59,359
44,660
0
14,699
0
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
Yes
Burden Increase Due to:
Miscellaneous Actions
Burden decreases because of Program Change due to Agency Discretion:
Yes
Burden Reduction Due to:
Miscellaneous Actions
Short Statement:
Currently, there are 58,159 reporting and record keeping burden hours in the OMB inventory. HRSA is requesting 59,359 burden hours, an increase of 1,200 hours. The anticipated burden has increased due to updates made to the estimated number of covered entity respondents and responses per respondent based on 2021 registration and recertification data. All changes in burden hours are due to adjustments in agency estimates due to the potential number of respondents, which is not a result of any action of the Federal government.
Annual Cost to Federal Government:
$4,611,195
Does this IC contain surveys, censuses, or employ statistical methods?
No
Does this ICR request any personally identifiable information (see
OMB Circular No. A-130
for an explanation of this term)? Please consult with your agency's privacy program when making this determination.
No
Does this ICR include a form that requires a Privacy Act Statement (see
5 U.S.C. §552a(e)(3)
)? Please consult with your agency's privacy program when making this determination.
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
Yes
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
No
Agency Contact:
Laura Cooper 301 443-2126 lcooper@hrsa.gov
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
11/29/2022
An official website of the United States government
The .gov means it's official.
The site is secure.
